Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check5 days agoChange DetectedRevision indicator updated from v3.3.1 to v3.3.2 on the page footer, with no observed changes to study details, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and may not all relate to the study. The page revision has been updated to v3.3.1.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding/operating status notice was removed from the page; other study details, eligibility criteria, and trial information appear unchanged.SummaryDifference0.4%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe update shows minor UI adjustments and a refreshed last-updated date, with no changes to core study information such as eligibility, interventions, outcomes, or participating sites. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference3%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.